{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:49:22Z","timestamp":1760820562095},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T00:00:00Z","timestamp":1384819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00423-013-1144-8","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T04:00:59Z","timestamp":1384747259000},"page":"41-53","source":"Crossref","is-referenced-by-count":9,"title":["Surgical treatment of peritoneal carcinomatosis: current treatment modalities"],"prefix":"10.1007","volume":"399","author":[{"given":"Yakup","family":"Kulu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beat","family":"M\u00fcller-Stich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus W.","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,19]]},"reference":[{"key":"1144_CR1","first-page":"256","volume":"40","author":"JS Spratt","year":"1980","unstructured":"Spratt JS, Adcock RA, Muskovin M et al (1980) Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 40:256\u2013260","journal-title":"Cancer Res"},{"key":"1144_CR2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/BF02554625","volume":"30","author":"PH Sugarbaker","year":"1987","unstructured":"Sugarbaker PH, Kern K, Lack E (1987) Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment. Dis Colon Rectum 30:772\u2013779","journal-title":"Dis Colon Rectum"},{"key":"1144_CR3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02053933","volume":"36","author":"PH Sugarbaker","year":"1993","unstructured":"Sugarbaker PH, Zhu BW, Sese GB, Shmookler B (1993) Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 36:323\u2013329","journal-title":"Dis Colon Rectum"},{"key":"1144_CR4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejso.2011.04.007","volume":"37","author":"PH Sugarbaker","year":"2011","unstructured":"Sugarbaker PH, Van der Speeten K, Anthony Stuart O, Chang D (2011) Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis. Eur J Surg Oncol 37:719\u2013726","journal-title":"Eur J Surg Oncol"},{"key":"1144_CR5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/089686080302300605","volume":"23","author":"M Flessner","year":"2003","unstructured":"Flessner M, Henegar J, Bigler S, Genous L (2003) Is the peritoneum a significant transport barrier in peritoneal dialysis? Perit Dial Int 23:542\u2013549","journal-title":"Perit Dial Int"},{"key":"1144_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00280-003-0626-8","volume":"52","author":"VV Lima de","year":"2003","unstructured":"de Lima VV, Stuart OA, Mohamed F, Sugarbaker PH (2003) Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. Cancer Chemother Pharmacol 52:108\u2013112","journal-title":"Cancer Chemother Pharmacol"},{"key":"1144_CR7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00280-008-0800-0","volume":"63","author":"K Speeten Van der","year":"2009","unstructured":"Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH (2009) A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin. Cancer Chemother Pharmacol 63:799\u2013805","journal-title":"Cancer Chemother Pharmacol"},{"key":"1144_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.soc.2012.07.013","volume":"21","author":"K Speeten Van der","year":"2012","unstructured":"Van der Speeten K, Stuart OA, Sugarbaker PH (2012) Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy. Surg Oncol Clin N Am 21:577\u2013597","journal-title":"Surg Oncol Clin N Am"},{"key":"1144_CR9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1634\/theoncologist.10-2-112","volume":"10","author":"PH Sugarbaker","year":"2005","unstructured":"Sugarbaker PH, Mora JT, Carmignani P et al (2005) Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 10:112\u2013122","journal-title":"Oncologist"},{"key":"1144_CR10","first-page":"161862","volume":"2011","author":"PH Sugarbaker","year":"2011","unstructured":"Sugarbaker PH, Stuart OA, Bijelic L (2011) Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data. Int J Surg Oncol 2011:161862","journal-title":"Int J Surg Oncol"},{"key":"1144_CR11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1023\/B:PHAM.0000026444.67883.83","volume":"21","author":"E Jerremalm","year":"2004","unstructured":"Jerremalm E, Hedeland M, Wallin I et al (2004) Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex. Pharm Res 21:891\u2013894","journal-title":"Pharm Res"},{"key":"1144_CR12","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1245\/s10434-012-2229-2","volume":"19","author":"PH Sugarbaker","year":"2012","unstructured":"Sugarbaker PH (2012) Parietal peritonectomy. Ann Surg Oncol 19:1250","journal-title":"Ann Surg Oncol"},{"key":"1144_CR13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1023791229361","volume":"22","author":"CP Carmignani","year":"2003","unstructured":"Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH (2003) Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 22:465\u2013472","journal-title":"Cancer Metastasis Rev"},{"key":"1144_CR14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jso.21484","volume":"101","author":"PH Sugarbaker","year":"2010","unstructured":"Sugarbaker PH (2010) Pont hepatique (hepatic bridge), an important anatomic structure in cytoreductive surgery. J Surg Oncol 101:251\u2013252","journal-title":"J Surg Oncol"},{"key":"1144_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jso.21058","volume":"98","author":"S Kusamura","year":"2008","unstructured":"Kusamura S, O'Dwyer ST, Baratti D et al (2008) Technical aspects of cytoreductive surgery. J Surg Oncol 98:232\u2013236","journal-title":"J Surg Oncol"},{"key":"1144_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.21061","volume":"98","author":"O Glehen","year":"2008","unstructured":"Glehen O, Cotte E, Kusamura S et al (2008) Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion. J Surg Oncol 98:242\u2013246","journal-title":"J Surg Oncol"},{"key":"1144_CR17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.soc.2012.07.001","volume":"21","author":"S Gonzalez-Moreno","year":"2012","unstructured":"Gonzalez-Moreno S, Gonzalez-Bayon L, Ortega-Perez G (2012) Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations. Surg Oncol Clin N Am 21:543\u2013557","journal-title":"Surg Oncol Clin N Am"},{"key":"1144_CR18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004230050246","volume":"384","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH (1999) Management of peritoneal-surface malignancy: the surgeon's role. Langenbecks Arch Surg 384:576\u2013587","journal-title":"Langenbecks Arch. Surg."},{"key":"1144_CR19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jso.20370","volume":"92","author":"PH Sugarbaker","year":"2005","unstructured":"Sugarbaker PH (2005) An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Oncol 92:142\u2013146","journal-title":"J Surg Oncol"},{"key":"1144_CR20","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1517\/14656560903044974","volume":"10","author":"PH Sugarbaker","year":"2009","unstructured":"Sugarbaker PH (2009) Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach. Expert Opin Pharmacother 10:1965\u20131977","journal-title":"Expert Opin Pharmacother"},{"key":"1144_CR21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","volume":"203","author":"RG Silva da","year":"2006","unstructured":"da Silva RG, Sugarbaker PH (2006) Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 203:878\u2013886","journal-title":"J Am Coll Surg"},{"key":"1144_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F et al (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63\u201368","journal-title":"J Clin Oncol"},{"key":"1144_CR23","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J","volume":"88","author":"AC Beaujard","year":"2000","unstructured":"Beaujard AC, Glehen O, Caillot JL et al (2000) Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88:2512\u20132519","journal-title":"Cancer"},{"key":"1144_CR24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/JCO.2003.06.139","volume":"21","author":"O Glehen","year":"2003","unstructured":"Glehen O, Mithieux F, Osinsky D et al (2003) Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 21:799\u2013806","journal-title":"J Clin Oncol"},{"key":"1144_CR25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359\u2013374","journal-title":"Cancer Treat Res"},{"key":"1144_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7800-2-3","volume":"2","author":"RL Harmon","year":"2005","unstructured":"Harmon RL, Sugarbaker PH (2005) Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2:3","journal-title":"Int Semin Surg Oncol"},{"key":"1144_CR27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00000658-199402000-00002","volume":"219","author":"DB Gough","year":"1994","unstructured":"Gough DB, Donohue JH, Schutt AJ et al (1994) Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 219:112\u2013119","journal-title":"Ann Surg"},{"key":"1144_CR28","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","volume":"19","author":"BM Ronnett","year":"1995","unstructured":"Ronnett BM, Zahn CM, Kurman RJ et al (1995) Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \"pseudomyxoma peritonei\". Am J Surg Pathol 19:1390\u20131408","journal-title":"Am J Surg Pathol"},{"key":"1144_CR29","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH et al (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449\u20132456","journal-title":"J Clin Oncol"},{"key":"1144_CR30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-006-9182-x","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Black D, Savady R, Sugarbaker PH (2007) A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 14:484\u2013492","journal-title":"Ann Surg Oncol"},{"key":"1144_CR31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jss.2012.12.040","volume":"183","author":"K McBride","year":"2013","unstructured":"McBride K, McFadden D, Osler T (2013) Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis. J Surg Res 183:246\u2013252","journal-title":"J Surg Res"},{"key":"1144_CR32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.sla.0000152015.76731.1f","volume":"241","author":"TJ Miner","year":"2005","unstructured":"Miner TJ, Shia J, Jaques DP et al (2005) Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 241:300\u2013308","journal-title":"Ann Surg"},{"key":"1144_CR33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","volume":"36","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Quenet F et al (2010) Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 36:456\u2013462","journal-title":"Eur J Surg Oncol"},{"key":"1144_CR34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1245\/s10434-011-1903-0","volume":"19","author":"HE Halabi","year":"2012","unstructured":"Halabi HE, Gushchin V, Francis J et al (2012) Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer. Ann Surg Oncol 19:122\u2013125","journal-title":"Ann Surg Oncol"},{"key":"1144_CR35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s10434-006-9708-2","volume":"13","author":"JHT Stewart","year":"2006","unstructured":"Stewart JHT (2006) Shen P, Russell GB et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 13:624\u2013634","journal-title":"Ann Surg Oncol"},{"key":"1144_CR36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358\u2013363","journal-title":"Cancer"},{"key":"1144_CR37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD et al (2012) Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 30:263\u2013267","journal-title":"J Clin Oncol"},{"key":"1144_CR38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","volume":"38","author":"YL Klaver","year":"2012","unstructured":"Klaver YL, Simkens LH, Lemmens VE et al (2012) Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol 38:617\u2013623","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"1144_CR39","first-page":"15","volume":"7","author":"KL McBride","year":"1989","unstructured":"McBride KL (1989) Total reconstruction of the temporomandibular joint with the Vitek-Kent prostheses. TMJ Update 7(1):15\u201318","journal-title":"TMJ Update"},{"key":"1144_CR40","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1245\/s10434-009-0487-4","volume":"16","author":"C Cao","year":"2009","unstructured":"Cao C, Yan TD, Black D, Morris DL (2009) A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 16:2152\u20132165","journal-title":"Ann Surg Oncol"},{"key":"1144_CR41","first-page":"5790","volume":"50","author":"PH Sugarbaker","year":"1990","unstructured":"Sugarbaker PH, Graves T, DeBruijn EA et al (1990) Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 50:5790\u20135794","journal-title":"Cancer Res"},{"key":"1144_CR42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1245\/s10434-006-9167-9","volume":"14","author":"D Elias","year":"2007","unstructured":"Elias D, Benizri E, Di Pietrantonio D et al (2007) Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 14:509\u2013514","journal-title":"Ann Surg Oncol"},{"key":"1144_CR43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/annonc\/mdr301","volume":"23","author":"PH Cashin","year":"2012","unstructured":"Cashin PH, Graf W, Nygren P, Mahteme H (2012) Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case\u2013control study. Ann Oncol 23:647\u2013652","journal-title":"Ann Oncol"},{"key":"1144_CR44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jso.23276","volume":"107","author":"YJ McConnell","year":"2013","unstructured":"McConnell YJ, Mack LA, Francis WP et al (2013) HIPEC\u2009+\u2009EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy. J Surg Oncol 107:591\u2013596","journal-title":"J Surg Oncol"},{"issue":"Suppl","key":"1144_CR45","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/s002800051093","volume":"43","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43(Suppl):S15\u201325","journal-title":"Cancer Chemother Pharmacol"},{"key":"1144_CR46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681\u2013685","journal-title":"J Clin Oncol"},{"key":"1144_CR47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/SLA.0b013e31822638f6","volume":"254","author":"D Elias","year":"2011","unstructured":"Elias D, Honore C, Dumont F et al (2011) Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 254:289\u2013293","journal-title":"Ann Surg"},{"key":"1144_CR48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/SLA.0b013e3182778089","volume":"258","author":"L Maggiori","year":"2012","unstructured":"Maggiori L, Goere D, Viana B et al (2012) Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent?: a case\u2013control study. Ann Surg 258:116\u201321","journal-title":"Ann Surg"},{"key":"1144_CR49","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1245\/s10434-010-1415-3","volume":"18","author":"G Glockzin","year":"2011","unstructured":"Glockzin G, Renner P, Popp FC et al (2011) Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 18:1052\u20131059","journal-title":"Ann Surg Oncol"},{"key":"1144_CR50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ctrv.2012.11.003","volume":"39","author":"EM Cuba de","year":"2013","unstructured":"de Cuba EM, Kwakman R, Knol DL et al (2013) Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev 39:321\u2013327","journal-title":"Cancer Treat Rev"},{"key":"1144_CR51","doi-asserted-by":"crossref","unstructured":"Wagner AD, Unverzagt S, Grothe W et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 2010; CD004064.","DOI":"10.1002\/14651858.CD004064.pub3"},{"key":"1144_CR52","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jso.22017","volume":"104","author":"RS Gill","year":"2011","unstructured":"Gill RS, Al-Adra DP, Nagendran J et al (2011) Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol 104:692\u2013698","journal-title":"J Surg Oncol"},{"key":"1144_CR53","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C et al (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17:2370\u20132377","journal-title":"Ann Surg Oncol"},{"key":"1144_CR54","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols RF, Bundy BN, Greer BE et al (2003) Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21:3194\u20133200","journal-title":"J Clin Oncol"},{"key":"1144_CR55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343","journal-title":"N Engl J Med"},{"key":"1144_CR56","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","volume":"135","author":"TC Chua","year":"2009","unstructured":"Chua TC, Robertson G, Liauw W et al (2009) Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results. J Cancer Res Clin Oncol 135:1637\u20131645","journal-title":"J Cancer Res Clin Oncol"},{"key":"1144_CR57","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","volume":"127","author":"A Fagotti","year":"2012","unstructured":"Fagotti A, Costantini B, Petrillo M et al (2012) Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case\u2013control study on survival in patients with two year follow-up. Gynecol Oncol 127:502\u2013505","journal-title":"Gynecol Oncol"},{"key":"1144_CR58","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P (2007) Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 18:985\u2013990","journal-title":"Ann Oncol"},{"key":"1144_CR59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X","volume":"70","author":"GH Eltabbakh","year":"1999","unstructured":"Eltabbakh GH, Piver MS, Hempling RE et al (1999) Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 70:6\u201312","journal-title":"J Surg Oncol"},{"key":"1144_CR60","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636\u20132644","journal-title":"J Clin Oncol"},{"key":"1144_CR61","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jso.21055","volume":"98","author":"M Deraco","year":"2008","unstructured":"Deraco M, Bartlett D, Kusamura S, Baratti D (2008) Consensus statement on peritoneal mesothelioma. J Surg Oncol 98:268\u2013272","journal-title":"J Surg Oncol"},{"key":"1144_CR62","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"AL Feldman","year":"2003","unstructured":"Feldman AL, Libutti SK, Pingpank JF et al (2003) Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 21:4560\u20134567","journal-title":"J Clin Oncol"},{"key":"1144_CR63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1245\/s10434-006-9187-5","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Edwards G, Alderman R et al (2007) Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma\u2013a prospective study of 70 consecutive cases. Ann Surg Oncol 14:515\u2013525","journal-title":"Ann Surg Oncol"},{"key":"1144_CR64","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237\u20136242","journal-title":"J Clin Oncol"},{"key":"1144_CR65","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1365-2168.2000.01571.x","volume":"87","author":"G Sebbag","year":"2000","unstructured":"Sebbag G, Yan H, Shmookler BM et al (2000) Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 87:1587\u20131593","journal-title":"Br J Surg"},{"key":"1144_CR66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Brun EA, Cerruto CA et al (2007) Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 14:41\u201349","journal-title":"Ann Surg Oncol"},{"key":"1144_CR67","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-012-2237-2","volume":"19","author":"D Baratti","year":"2012","unstructured":"Baratti D, Kusamura S, Cabras AD, Deraco M (2012) Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study. Ann Surg Oncol 19:1416\u20131424","journal-title":"Ann Surg Oncol"},{"key":"1144_CR68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jso.21054","volume":"98","author":"B Moran","year":"2008","unstructured":"Moran B, Baratti D, Yan TD et al (2008) Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 98:277\u2013282","journal-title":"J Surg Oncol"},{"key":"1144_CR69","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737\u20133743","journal-title":"J Clin Oncol"},{"key":"1144_CR70","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH et al (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284\u20133292","journal-title":"J Clin Oncol"},{"key":"1144_CR71","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 249:900\u2013907","journal-title":"Ann Surg"},{"key":"1144_CR72","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/S1470-2045(12)70210-3","volume":"13","author":"PH Sugarbaker","year":"2012","unstructured":"Sugarbaker PH, Ryan DP (2012) Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol 13:e362\u2013369","journal-title":"Lancet Oncol"},{"key":"1144_CR73","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1245\/s10434-012-2241-6","volume":"19","author":"F Austin","year":"2012","unstructured":"Austin F, Mavanur A, Sathaiah M et al (2012) Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol 19:1386\u20131393","journal-title":"Ann Surg Oncol"},{"key":"1144_CR74","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1245\/s10434-011-1714-3","volume":"18","author":"TC Chua","year":"2011","unstructured":"Chua TC, Al-Alem I, Saxena A et al (2011) Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patients. Ann Surg Oncol 18:1540\u20131546","journal-title":"Ann Surg Oncol"},{"key":"1144_CR75","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1245\/s10434-012-2264-z","volume":"19","author":"D Hompes","year":"2012","unstructured":"Hompes D, D'Hoore A, Van Cutsem E et al (2012) The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Ann Surg Oncol 19:2186\u20132194","journal-title":"Ann Surg Oncol"},{"key":"1144_CR76","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ejso.2012.03.001","volume":"38","author":"PH Cashin","year":"2012","unstructured":"Cashin PH, Graf W, Nygren P, Mahteme H (2012) Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study. Eur J Surg Oncol 38:509\u2013515","journal-title":"Eur J Surg Oncol"},{"key":"1144_CR77","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","volume":"254","author":"F Quenet","year":"2011","unstructured":"Quenet F, Goere D, Mehta SS et al (2011) Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg 254:294\u2013301","journal-title":"Ann Surg"},{"key":"1144_CR78","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/SLA.0b013e3181d9765d","volume":"251","author":"D Elias","year":"2010","unstructured":"Elias D, Glehen O, Pocard M et al (2010) A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix. Ann Surg 251:896\u2013901","journal-title":"Ann Surg"},{"key":"1144_CR79","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1002\/cncr.25116","volume":"116","author":"J Franko","year":"2010","unstructured":"Franko J, Ibrahim Z, Gusani NJ et al (2010) Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 116:3756\u20133762","journal-title":"Cancer"},{"key":"1144_CR80","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T et al (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18:1575\u20131581","journal-title":"Ann Surg Oncol"},{"key":"1144_CR81","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jso.21519","volume":"101","author":"XJ Yang","year":"2010","unstructured":"Yang XJ, Li Y, Yonemura Y (2010) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and\/or peritoneal carcinomatosis: results from a Chinese center. J Surg Oncol 101:457\u2013464","journal-title":"J Surg Oncol"},{"key":"1144_CR82","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/bjs.4695","volume":"92","author":"Y Yonemura","year":"2005","unstructured":"Yonemura Y, Kawamura T, Bandou E et al (2005) Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 92:370\u2013375","journal-title":"Br J Surg"},{"key":"1144_CR83","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1245\/s10434-012-2510-4","volume":"19","author":"N Bakrin","year":"2012","unstructured":"Bakrin N, Cotte E, Golfier F et al (2012) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients. Ann Surg Oncol 19:4052\u20134058","journal-title":"Ann Surg Oncol"},{"key":"1144_CR84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","volume":"122","author":"M Deraco","year":"2011","unstructured":"Deraco M, Kusamura S, Virzi S et al (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. Gynecol Oncol 122:215\u2013220","journal-title":"Gynecol Oncol"},{"key":"1144_CR85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/IGC.0b013e3181c50cde","volume":"20","author":"CW Helm","year":"2010","unstructured":"Helm CW, Richard SD, Pan J et al (2010) Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer 20:61\u201369","journal-title":"Int J Gynecol Cancer"},{"key":"1144_CR86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23553","volume":"113","author":"A Giorgio Di","year":"2008","unstructured":"Di Giorgio A, Naticchioni E, Biacchi D et al (2008) Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 113:315\u2013325","journal-title":"Cancer"},{"key":"1144_CR87","first-page":"890450","volume":"2012","author":"L Bijelic","year":"2012","unstructured":"Bijelic L, Stuart OA, Sugarbaker P (2012) Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma. Gastroenterol Res Pract 2012:890450","journal-title":"Gastroenterol Res Pract"},{"key":"1144_CR88","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/bjs.4862","volume":"92","author":"J Bryant","year":"2005","unstructured":"Bryant J, Clegg AJ, Sidhu MK et al (2005) Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei. Br J Surg 92:153\u2013158","journal-title":"Br J Surg"},{"key":"1144_CR89","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H et al (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426\u20132432","journal-title":"Ann Surg Oncol"},{"key":"1144_CR90","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1200\/JCO.2006.07.1142","volume":"24","author":"TD Yan","year":"2006","unstructured":"Yan TD, Black D, Savady R, Sugarbaker PH (2006) Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24:4011\u20134019","journal-title":"J Clin Oncol"},{"key":"1144_CR91","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","volume":"18","author":"TD Yan","year":"2007","unstructured":"Yan TD, Welch L, Black D, Sugarbaker PH (2007) A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 18:827\u2013834","journal-title":"Ann Oncol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-013-1144-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-013-1144-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-013-1144-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T05:46:18Z","timestamp":1596865578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-013-1144-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,19]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1007\/s00423-013-1144-8","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,19]]}}}